共 87 条
[1]
Moss AJ(1996)Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1933-40
[2]
Hall WJ(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 877-83
[3]
Cannom DS(2005)Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 225-37
[4]
Moss AJ(2012)Preventive Effectiveness of Implantable Cardioverter Defibrillator in Reducing Sudden Cardiac Death in the Chinese Population: A Multicenter Trial of ICD Therapy versus Non-ICD Therapy J Cardiovasc Electrophysiol 23 s5-9
[5]
Zareba W(2008)Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 1357-65
[6]
Hall WJ(2012)Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study Pacing Clin Electrophysiol 35 863-9
[7]
Bardy GH(2003)Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID Pacing Clin Electrophysiol 26 1511-8
[8]
Lee KL(2009)Therapy with an implantable cardioverter defibrillator (ICD) in patients with coronary artery disease and dilated cardiomyopathy: benefits and disadvantages Swiss Med Wkly 139 647-53
[9]
Mark DB(2012)The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: an European analysis Eur Heart J 34 211-9
[10]
Hua W(2006)ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Asso